单克隆抗体
分泌物
三型分泌系统
抗生素
毒力
计算生物学
小分子
病菌
生物
临床疗效
抗体
微生物学
医学
免疫学
生物化学
基因
外科
作者
Alyssa C. Fasciano,Lamyaa Shaban,Joan Mecsas
出处
期刊:Ecosal plus
[American Society for Microbiology]
日期:2019-02-06
卷期号:8 (2)
被引量:27
标识
DOI:10.1128/ecosalplus.esp-0032-2018
摘要
Antibiotic resistance is a major public health threat that has stimulated the scientific community to search for nontraditional therapeutic targets. Because virulence, but not the growth, of many Gram-negative bacterial pathogens depends on the multicomponent type three secretion system injectisome (T3SSi), the T3SSi has been an attractive target for identifying small molecules, peptides, and monoclonal antibodies that inhibit its function to render the pathogen avirulent. While many small-molecule lead compounds have been identified in whole-cell-based high-throughput screens (HTSs), only a few protein targets of these compounds are known; such knowledge is an important step to developing more potent and specific inhibitors. Evaluation of the efficacy of compounds in animal studies is ongoing. Some efforts involving the development of antibodies and vaccines that target the T3SSi are further along and include an antibody that is currently in phase II clinical trials. Continued research into these antivirulence therapies, used alone or in combination with traditional antibiotics, requires combined efforts from both pharmaceutical companies and academic labs.
科研通智能强力驱动
Strongly Powered by AbleSci AI